Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.SummaryDifference0.5%

- Check20 days agoChange DetectedA site-wide funding status notice was added and the revision history was updated to version v3.4.1 (removing v3.4.0).SummaryDifference0.6%

- Check28 days agoChange DetectedAdded a new 'Show glossary' option and updated the revision to v3.4.0. Capitalization changes were made to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Pennsylvania (Philadelphia) as a trial site and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the older Pennsylvania Locations entry (v3.3.2).SummaryDifference0.3%

- Check91 days agoChange DetectedThe page shows a new revision tag: v3.3.2, replacing v3.2.0. No substantive changes to trial information are evident.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.